Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Cellectar Biosciences stock (CLRB)

Buy Cellectar Biosciences stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Cellectar Biosciences is a biotechnology business based in the US. Cellectar Biosciences shares (CLRB) are listed on the NASDAQ and all prices are listed in US Dollars. Cellectar Biosciences employs 20 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Cellectar Biosciences stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Cellectar Biosciences stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CLRB. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Cellectar Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Cellectar Biosciences stock price (NASDAQ: CLRB)

Use our graph to track the performance of CLRB stocks over time.

Cellectar Biosciences shares at a glance

Information last updated 2024-07-21.
Latest market close$2.52
52-week range$1.56 - $4.45
50-day moving average $2.87
200-day moving average $3.06
Wall St. target price$12.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.09

Is it a good time to buy Cellectar Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cellectar Biosciences price performance over time

Historical closes compared with the close of $2.52 from 2024-07-19

1 week (2024-07-16) -9.68%
1 month (2024-06-21) -11.89%
3 months (2024-04-23) -18.97%
6 months (2024-01-23) -31.71%
1 year (2023-07-21) 21.74%
2 years (2022-07-22) -49.09%
3 years (2021-07-23) 125.00%
5 years (2019-07-23) 18.31%

Cellectar Biosciences financials

Gross profit TTM $0
Return on assets TTM -91.47%
Return on equity TTM -304.38%
Profit margin 0%
Book value $0.27
Market Capitalization $90.3 million

TTM: trailing 12 months

Cellectar Biosciences share dividends

We're not expecting Cellectar Biosciences to pay a dividend over the next 12 months.

Have Cellectar Biosciences's shares ever split?

Cellectar Biosciences's shares were split on a 1:10 basis on 21 July 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellectar Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Cellectar Biosciences shares which in turn could have impacted Cellectar Biosciences's share price.

Cellectar Biosciences share price volatility

Over the last 12 months, Cellectar Biosciences's shares have ranged in value from as little as $1.5602 up to $4.45. A popular way to gauge a stock's volatility is its "beta".

CLRB.US volatility(beta: 0.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellectar Biosciences's is 0.986. This would suggest that Cellectar Biosciences's shares are less volatile than average (for this exchange).

Cellectar Biosciences overview

Cellectar Biosciences, Inc. , a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey. .

Frequently asked questions

What percentage of Cellectar Biosciences is owned by insiders or institutions?
Currently 3.202% of Cellectar Biosciences shares are held by insiders and 31.21% by institutions.
How many people work for Cellectar Biosciences?
Latest data suggests 20 work at Cellectar Biosciences.
When does the fiscal year end for Cellectar Biosciences?
Cellectar Biosciences's fiscal year ends in December.
Where is Cellectar Biosciences based?
Cellectar Biosciences's address is: 100 Campus Drive, Florham Park, NJ, United States, 07932
What is Cellectar Biosciences's ISIN number?
Cellectar Biosciences's international securities identification number is: US15117F5008
What is Cellectar Biosciences's CUSIP number?
Cellectar Biosciences's Committee on Uniform Securities Identification Procedures number is: 67000M100

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site